Bingöl
Bingoel, Turkey (Türkiye)
Location status: Recruiting
Location contact
Büşra Candiri, asst. prof
CONTACT
Hasan BİNGÖL, asst. prof
CONTACT
NCT Number: NCT07287215
The main purpose of this study was to examine the relationship between motor imagery capacity and functional mobility, walking and balance in children with diplegic type cerebral palsy.
Interested in participating?
Request Info5 year–18 year
All sexes
Observational
Bingoel, Turkey (Türkiye)
Location status: Recruiting
Büşra Candiri, asst. prof
CONTACT
Hasan BİNGÖL, asst. prof
CONTACT
This study will be conducted using a cross-sectional and correlational screening model to examine the relationship between motor imagery ability and functional mobility, walking, and balance in children with diplegic cerebral palsy. Data collection will be conducted through one-on-one assessments after obtaining written consent from volunteer participants and their families. The data collection tools used in the study are listed below: Demographic Information Form, Motor Imagery Ability Assessment, Mental Stopwatch Paradigm, Functional Mobility, and Gait Assessment.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Laterality Task (Choice Task): Implicit Motor Imagery capacity will be measured through a laterality task, which involves deciding which side a limb belongs to. Right-left discrimination of the foot will be assessed using the "Recognize Foot" application developed by the Neuro Orthopaedic Institute
A mental stopwatch will be used to assess explicit MI capacity. This paradigm compares the time between the actual movement duration and the duration of a similar imagined task.
Functional Mobility: Functional Mobility will be assessed using the Functional Mobility Scale (FMS) and the Timed Up and Go test.
Gait assessment: The Gillette FDA is a self- or observer-based assessment tool.
Time frame: 24-48 hours
A mental stopwatch will be used to assess explicit MI capacity. This paradigm compares the time between the actual movement duration and the duration of a similar imagined task.
Time frame: 24-48 hours
Laterality Task (Choice Task): Implicit Motor Imagery capacity will be measured through a laterality task, which involves deciding which side a limb belongs to. Right-left discrimination of the foot will be assessed using the "Recognize Foot" application developed by the Neuro Orthopaedic Institute
Time frame: 24-48 hours
Functional Mobility: Functional Mobility will be assessed using the Functional Mobility Scale (FMS)
Time frame: 24-48 hours
Functional Mobility: Functional Mobility will be assessed using the Timed Up and Go test.
Time frame: 24-48 hours
Gait assessment: The Gillette Functional Assessment Questionnaire is a self- or observer-based assessment tool, minimum score 22 maximum score 88
Contact information is provided by the study sponsor or research team.
Inonu University
Other
Investigation of the Relationship Between Motor Imagery Ability and Functional Mobility, Walking, and Balance in Children With Diplegic Cerebral Palsy
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07488429
Brain Damage, Chronic, Brain Diseases
Ankara, Turkey (Türkiye)
View Trial DetailsNCT05025007
Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities
Ankara, Turkey (Türkiye)
View Trial DetailsNCT05500924
Diplegic Cerebral Palsy With Spasticity
Bethlehem, Palestinian Territories
View Trial DetailsNCT06588894
Cognitive Function, Diabetes Mellitus
Kütahya, Central, Turkey (Türkiye)
View Trial Details